InSilicoMinds

Hyderabad, India Founded: 2021 • Age: 5 yrs
Provides AI modeling and simulation services for pharma and life sciences industries.

About InSilicoMinds

InSilicoMinds is a Technology company based in Hyderabad (India) founded in 2021 by Nirnith Devireddy. It provides AI modeling and simulation services for pharma and life sciences industries. It operates on a B2B and Consulting model in Technology and Healthcare sectors. Its chief executive, as recorded, is Nirnith Devireddy. Its Indian entity Ikiminds Private Limited reported revenue of β‚Ή1.16 Cr. InSilicoMinds offers products and services including Generics Solutions, Vaccines Development, Drug Discovery, Small Molecules, and Large Molecules. Its focus areas include Biotech, Simulation Services, API Development and AI Optimization.

Company details

InSilicoMinds specializes in AI, advanced modeling, and simulation to optimize drug development processes for pharmaceutical and life sciences sectors. They offer solutions like Generics, Vaccines, and Drug Discovery, using computational methods to reduce costs and time while improving outcomes. Based in India and the USA, they collaborate with clients from startups to large corporations through consultancy and partnerships.

  • Headquarters Hyderabad, India
  • Employees 1
  • Founders Nirnith Devireddy
  • Sectors
    Technology
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website insilicominds.com
  • Social LinkedIn
  • Legal Name Ikiminds Private Limited
  • Date of Incorporation 29 Mar, 2022
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹1.16 Cr

    FY 2025 · +36% YoY

  • Net Profit
    ₹60,186

    FY 2025 · 1% margin

  • EBITDA
    ₹60,186

    FY 2025 · 1% margin

  • Employee Count
    1

Products & Services of InSilicoMinds

InSilicoMinds offers a comprehensive portfolio of products and services, including Generics Solutions, Vaccines Development, Drug Discovery, Small Molecules, and Large Molecules.

Generics Solutions
Drug Development

Uses computational methods to simulate and optimize generic drug formulations

Vaccines Development
Vaccine Tech

Streamlines vaccine creation with AI tools to reduce costs and risks

Drug Discovery
Research Tools

Applies digital simulations to accelerate new drug identification processes

Small Molecules
Molecular Modeling

Predicts behavior of small molecules in drug development via simulations

Large Molecules
Biotech Solutions

Optimizes large molecule drugs using AI for efficacy and safety

API Solutions
Production Tech

Enhances API production efficiency through predictive computational models

Board of directors of Ikiminds Private Limited (InSilicoMinds)

Ikiminds Private Limited is the primary company behind InSilicoMinds. The board of Ikiminds Private Limited currently have 2 directors; the longest-serving is Nirnith Reddy Devireddy, appointed in 2022. 1 earlier director has ceased.

DirectorDesignationAppointedTenureEntity
Nirnith Reddy Devireddy
DIN 09552432
Director29 Mar 20224 yrs 6 moIkiminds Private Limited
Srinath Reddy Devireddy
DIN 01780850
Additional Director25 May 20224 yrs 5 moIkiminds Private Limited

People of InSilicoMinds

1 people are tracked at InSilicoMinds (1 in leadership); the tracked headcount is 1.

NameRoleGroup
Co-Founder, CEOLeadership
Premium access

Complete people profiles for InSilicoMinds

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of InSilicoMinds

Figures of Ikiminds Private Limited, the primary company behind InSilicoMinds, for FY 2025. Revenue was ₹1.16 Cr (+36% year on year). Net profit was ₹60,186 (1% margin). EBITDA was ₹60,186 (1% margin).

  • ₹1.16 CrRevenue · FY 2025 · +36% YoY
  • ₹60,186Net profit · 1% margin
  • ₹60,186EBITDA · 1% margin
  • ₹1 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Ikiminds Private Limited are on its company page.

Premium access

Detailed financial statements for InSilicoMinds

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Web traffic of InSilicoMinds

The website of InSilicoMinds (insilicominds.com) receives about 5.6K visits a month.

  • Monthly visits
    5.6K

    ▲ 440.6% vs previous month

Top companies in AI in Life Sciences

3 companies that operate in the same segment as InSilicoMinds (AI in Life Sciences) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provides AI solutions and services for research publishing and communication.
2001Mumbai, Maharashtra, IndiaUSD 91.43 M1,025
Scientific communications, localization, and AI services for researchers and publishers.
2000Mumbai, Maharashtra, IndiaUSD 25.46 M243
Provides big data analytics solutions tailored for the life sciences sector.
2006Bengaluru, Karnataka, India
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Insilicominds

Premium access

Complete news archive for InSilicoMinds

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about InSilicoMinds

InSilicoMinds was founded in 2021.

InSilicoMinds is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Nirnith Devireddy is the CEO of InSilicoMinds, as recorded in our data. They have also founded this company.

InSilicoMinds has 1 employees.

The primary company behind InSilicoMinds, Ikiminds Private Limited, reported revenue of β‚Ή1.16 Cr for FY 2025, up 36% year on year.

InSilicoMinds specializes in AI, advanced modeling, and simulation to optimize drug development processes for pharmaceutical and life sciences sectors. They offer solutions like Generics, Vaccines, and Drug Discovery, using computational methods to reduce costs and time while improving outcomes. Based in India and the USA, they collaborate with clients from startups to large corporations through consultancy and partnerships.

InSilicoMinds offers Generics Solutions, Vaccines Development, Drug Discovery, Small Molecules, and 2 more products and services.

InSilicoMinds operates through Ikiminds Private Limited.

The legal entities of InSilicoMinds currently have 2 directors, including Srinath Reddy Devireddy, Nirnith Reddy Devireddy.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available